학술논문
공중보건약사 활용의 경제성 평가
이용수 118
- 영문명
- Economic Evaluation of Introducing Public Health Pharmacist
- 발행기관
- 대한약학회
- 저자명
- 김재원(Jaewon Kim) 최승미(Seung-Mi Choi) 김대원(Dae-Won Kim)
- 간행물 정보
- 『약학회지』제63권 제5호(2019년), 282~291쪽, 전체 10쪽
- 주제분류
- 의약학 > 기타의약학
- 파일형태
- 발행일자
- 2019.10.30
4,000원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.
국문 초록
영문 초록
This study was to evaluate economic impact of the Public Health Pharmacist, in a societal perspective. We set the work scope of Public Health Pharmacist as supporting of filling a prescription in public hospitals, medication counseling and night time pharmacist in health center. Clinical outcomes of Public Health Pharmacist included drug compliance increase, social hospitalization reduction, and late night pharmaceutical accessibility improvement. And as result of drug compliance increase, inappropriate medication discontinuation, subsequent drug-related morbidity and mortality reduction might take place. Economic outcomes included cost savings from direct medical cost reduction such as medication and healthcare utilization and indirect cost of family members and care-givers. Input costs for Public Health Pharmacist included payroll costs, indirect expenses for the personnel, health center operating expenses for night time, medical material expenses, and telephone and visiting expenses for medication counseling service. Model parameters for outcomes were derived from published literatures, and costs were from literatures and health insurance statistical data in Korea. Annual costs and benefits were estimated in the year of 2018. We assumed that 1,347 public health pharmacist would be in charge, and their service meet the need of over 65 population fully, and that of the whole population in Korea in case of the “public night pharmacy.” Cost for Public Health Pharmacist was ₩70,974,390,845 per year and benefit for Public Health Pharmacist was ₩180,167,236,698 per year. Benefit-to-cost ratio was 2.538:1 and net benefit was ₩109,192,845,853 per year. However, in a certain condition in sensitivity test, it was showed that benefit of Public Health Pharmacist may reduced considerably. This implied that the cost effectiveness and economic validity of Public Health Pharmacist depend on change of medical care utilization behaviors people. In conclusion, the economic validity of Public Health Pharmacist was at least neutral under several alternative scenarios.
목차
서 론(Introduction)
연구 방법(Research Methods)
결 과(Results)
고 찰(Discussion)
결 론(Conclusion)
해당간행물 수록 논문
- 공중보건약사 활용의 경제성 평가
- 고삼 추출물의 과민성 방광에 미치는 효과 및 급성독성 연구
- 고온용융 압출과 3차원 프린팅 접목을 통한 테오필린 함유 서방정 개발
- 적절하게 조절되지 않는 중증 천식환자에서 급성 악화 유형과 사망 및 의료비 발생 현황
- Beneficial Effects of Fermented Soybean through PPARs Activation in Metabolic Syndrome
- 설계기반품질고도화(QbD)의약품 개발을 위한 오픈소스 기반 실험설계 R 프로그램의 활용
- 미국·유럽연합·중국·일본·한국의 천연물의약품의 인허가제도 비교연구
- Modulatory Effects of Calorie Restriction on Senoinflammation Underlying Aging Process
- 정량적인 구조-활성상관(QSAR) 기법을 활용한 in silico 위해평가
참고문헌
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!